Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-01-20

Clinical Trial Update: Hyperpolarized Xenon Functional Lung Imaging in COPD Patients Undergoing Targeted Lung Denervation

View source ↗

Summary

The clinical trial evaluating hyperpolarized xenon imaging in COPD patients undergoing targeted lung denervation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Xemed LLC | Conditions: COPD | Status: WITHDRAWN